Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia

Despite development of comprehensive approaches to treat schizophrenia and other psychotic disorders and improve outcomes, there remains a proportion (approximately one-third) of patients who are treatment resistant and will not have remission of psychotic symptoms despite adequate trials of pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales: Crocker, Candice E., Tibbo, Philip G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201564/
https://www.ncbi.nlm.nih.gov/pubmed/30405407
http://dx.doi.org/10.3389/fphar.2018.01172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201564/
https://www.ncbi.nlm.nih.gov/pubmed/30405407
http://dx.doi.org/10.3389/fphar.2018.01172

Ejemplares similares